Identification of the organic anion transporting polypeptides responsible for the hepatic uptake of the major metabolite of epyrifenacil, S‐3100‐CA, in mice

Abstract Epyrifenacil is a novel herbicide that acts as an inhibitor of protoporphyrinogen oxidase (PPO) and produces hepatotoxicity in rodents by inhibiting PPO. Our previous research revealed that the causal substance of hepatotoxicity is S‐3100‐CA, a major metabolite of epyrifenacil, and that hum...

Full description

Bibliographic Details
Main Authors: Kengo Sakurai, Tomohiro Kuroda, Jun Abe, Hiroshi Toda, Sachiko Kitamoto
Format: Article
Language:English
Published: Wiley 2021-10-01
Series:Pharmacology Research & Perspectives
Subjects:
Online Access:https://doi.org/10.1002/prp2.877
id doaj-7a3eacb68306478f8d36c9eaa9956cf8
record_format Article
spelling doaj-7a3eacb68306478f8d36c9eaa9956cf82021-10-11T10:00:37ZengWileyPharmacology Research & Perspectives2052-17072021-10-0195n/an/a10.1002/prp2.877Identification of the organic anion transporting polypeptides responsible for the hepatic uptake of the major metabolite of epyrifenacil, S‐3100‐CA, in miceKengo Sakurai0Tomohiro Kuroda1Jun Abe2Hiroshi Toda3Sachiko Kitamoto4Environmental Health Science Laboratory Sumitomo Chemical Co., Ltd. Osaka JapanEnvironmental Health Science Laboratory Sumitomo Chemical Co., Ltd. Osaka JapanEnvironmental Health Science Laboratory Sumitomo Chemical Co., Ltd. Osaka JapanEnvironmental Health Science Laboratory Sumitomo Chemical Co., Ltd. Osaka JapanEnvironmental Health Science Laboratory Sumitomo Chemical Co., Ltd. Osaka JapanAbstract Epyrifenacil is a novel herbicide that acts as an inhibitor of protoporphyrinogen oxidase (PPO) and produces hepatotoxicity in rodents by inhibiting PPO. Our previous research revealed that the causal substance of hepatotoxicity is S‐3100‐CA, a major metabolite of epyrifenacil, and that human hepatocyte uptake of S‐3100‐CA was significantly lower than rodent one, suggesting less relevant to hepatotoxicity in humans. To clarify the species difference in the uptake of S‐3100‐CA, we focused on organic anion transporting polypeptides (OATPs) and carried out an uptake assay using human, rat, and mouse OATP hepatic isoforms‐expressing 293FT cells. As a result, all the examined OATPs were found to contribute to the S‐3100‐CA uptake, suggesting that the species difference was not due to the differences in selectivity toward OATP isoforms. When [14C]epyrifenacil was administered to mice, the liver concentration of S‐3100‐CA was higher in males than in females. Furthermore, when [14C]epyrifenacil was administered with OATP inhibitors, the liver/plasma ratio of S‐3100‐CA was significantly decreased by rifampicin, an Oatp1a1/Oatp1a4 inhibitor in mice, but not by digoxin, an Oatp1a4‐specific inhibitor. This result indicates that Oatp1a1, the predominant transporter in male mice, is the main contributor to the hepatic transport of S‐3100‐CA, and consequently to the gender difference. Moreover, we conclude that the species difference in the hepatic uptake of S‐3100‐CA observed in our previous research is not due to differences in the selectivity toward OATP isoforms but rather to the significantly higher expression of OATPs which mediate uptake of S‐3100‐CA in rodents than in humans.https://doi.org/10.1002/prp2.877active hepatic uptakeepyrifenacilgender differenceherbicidespecies differenceOATP
collection DOAJ
language English
format Article
sources DOAJ
author Kengo Sakurai
Tomohiro Kuroda
Jun Abe
Hiroshi Toda
Sachiko Kitamoto
spellingShingle Kengo Sakurai
Tomohiro Kuroda
Jun Abe
Hiroshi Toda
Sachiko Kitamoto
Identification of the organic anion transporting polypeptides responsible for the hepatic uptake of the major metabolite of epyrifenacil, S‐3100‐CA, in mice
Pharmacology Research & Perspectives
active hepatic uptake
epyrifenacil
gender difference
herbicide
species difference
OATP
author_facet Kengo Sakurai
Tomohiro Kuroda
Jun Abe
Hiroshi Toda
Sachiko Kitamoto
author_sort Kengo Sakurai
title Identification of the organic anion transporting polypeptides responsible for the hepatic uptake of the major metabolite of epyrifenacil, S‐3100‐CA, in mice
title_short Identification of the organic anion transporting polypeptides responsible for the hepatic uptake of the major metabolite of epyrifenacil, S‐3100‐CA, in mice
title_full Identification of the organic anion transporting polypeptides responsible for the hepatic uptake of the major metabolite of epyrifenacil, S‐3100‐CA, in mice
title_fullStr Identification of the organic anion transporting polypeptides responsible for the hepatic uptake of the major metabolite of epyrifenacil, S‐3100‐CA, in mice
title_full_unstemmed Identification of the organic anion transporting polypeptides responsible for the hepatic uptake of the major metabolite of epyrifenacil, S‐3100‐CA, in mice
title_sort identification of the organic anion transporting polypeptides responsible for the hepatic uptake of the major metabolite of epyrifenacil, s‐3100‐ca, in mice
publisher Wiley
series Pharmacology Research & Perspectives
issn 2052-1707
publishDate 2021-10-01
description Abstract Epyrifenacil is a novel herbicide that acts as an inhibitor of protoporphyrinogen oxidase (PPO) and produces hepatotoxicity in rodents by inhibiting PPO. Our previous research revealed that the causal substance of hepatotoxicity is S‐3100‐CA, a major metabolite of epyrifenacil, and that human hepatocyte uptake of S‐3100‐CA was significantly lower than rodent one, suggesting less relevant to hepatotoxicity in humans. To clarify the species difference in the uptake of S‐3100‐CA, we focused on organic anion transporting polypeptides (OATPs) and carried out an uptake assay using human, rat, and mouse OATP hepatic isoforms‐expressing 293FT cells. As a result, all the examined OATPs were found to contribute to the S‐3100‐CA uptake, suggesting that the species difference was not due to the differences in selectivity toward OATP isoforms. When [14C]epyrifenacil was administered to mice, the liver concentration of S‐3100‐CA was higher in males than in females. Furthermore, when [14C]epyrifenacil was administered with OATP inhibitors, the liver/plasma ratio of S‐3100‐CA was significantly decreased by rifampicin, an Oatp1a1/Oatp1a4 inhibitor in mice, but not by digoxin, an Oatp1a4‐specific inhibitor. This result indicates that Oatp1a1, the predominant transporter in male mice, is the main contributor to the hepatic transport of S‐3100‐CA, and consequently to the gender difference. Moreover, we conclude that the species difference in the hepatic uptake of S‐3100‐CA observed in our previous research is not due to differences in the selectivity toward OATP isoforms but rather to the significantly higher expression of OATPs which mediate uptake of S‐3100‐CA in rodents than in humans.
topic active hepatic uptake
epyrifenacil
gender difference
herbicide
species difference
OATP
url https://doi.org/10.1002/prp2.877
work_keys_str_mv AT kengosakurai identificationoftheorganicaniontransportingpolypeptidesresponsibleforthehepaticuptakeofthemajormetaboliteofepyrifenacils3100cainmice
AT tomohirokuroda identificationoftheorganicaniontransportingpolypeptidesresponsibleforthehepaticuptakeofthemajormetaboliteofepyrifenacils3100cainmice
AT junabe identificationoftheorganicaniontransportingpolypeptidesresponsibleforthehepaticuptakeofthemajormetaboliteofepyrifenacils3100cainmice
AT hiroshitoda identificationoftheorganicaniontransportingpolypeptidesresponsibleforthehepaticuptakeofthemajormetaboliteofepyrifenacils3100cainmice
AT sachikokitamoto identificationoftheorganicaniontransportingpolypeptidesresponsibleforthehepaticuptakeofthemajormetaboliteofepyrifenacils3100cainmice
_version_ 1716827871784206336